Ondine Biomedical Inc.
Develops photodisinfection therapies to combat antimicrobial resistance and prevent infections.
Overview
Corporate Details
- ISIN(s):
- CA68234M2058
- LEI:
- 9845005B69E07CGF4A56
- Country:
- Canada
- Address:
- SUITE 888 - 1100 MELVILLE ST, V6E 4A6 VANCOUVER
- Website:
- https://ondinebio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Ondine Biomedical Inc. is a life sciences company that develops and commercializes photodisinfection-based therapies to address the global challenge of antimicrobial resistance. The company's patented platform technology utilizes a photosensitive agent activated by non-thermal laser light to rapidly destroy a broad spectrum of pathogens, including drug-resistant bacteria, viruses, and fungi, without generating resistance. Its flagship product, Steriwave™, is a nasal decolonization therapy used in healthcare settings to prevent healthcare-associated infections (HAIs), such as surgical site infections. Ondine is also advancing a pipeline of products for applications including chronic rhinosinusitis, wound care, and ventilator-associated pneumonia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-23 08:00 |
Environmental & Social Information
Steriwave Now Protecting Patients with Cancer
|
English | 18.5 KB | ||
| 2025-09-19 08:00 |
Report Publication Announcement
Notice of Interim Results & Investor Presentation
|
English | 12.3 KB | ||
| 2025-09-18 18:55 |
Regulatory News Service
Ondine Presents Major Economic Benefits at ICPIC
|
English | 22.2 KB | ||
| 2025-09-15 11:44 |
Regulatory News Service
Steriwave proven to be effective against C Auris
|
English | 18.0 KB | ||
| 2025-09-10 08:00 |
Regulatory News Service
Steriwave Featured on CNBC’s Worldwide Exchange
|
English | 15.2 KB | ||
| 2025-09-08 08:00 |
Major Shareholding Notification
Notification of major holdings - hInsight
|
English | 54.0 KB | ||
| 2025-09-04 18:29 |
Major Shareholding Notification
Notification of major holdings - Pentwater
|
English | 40.8 KB | ||
| 2025-09-04 18:27 |
Major Shareholding Notification
Notification of major holdings - Albemarle
|
English | 69.2 KB | ||
| 2025-09-03 08:00 |
Regulatory News Service
Ondine to present Health Economic Data at ICPIC
|
English | 14.7 KB | ||
| 2025-08-27 17:52 |
Share Issue/Capital Change
Proposed c.£11m Fundraise
|
English | 155.0 KB | ||
| 2025-08-13 11:52 |
Regulatory News Service
First Mexican Hospital Steriwave Deployment
|
English | 14.8 KB | ||
| 2025-07-22 18:38 |
Share Issue/Capital Change
Share Issuance for ICU Study Enrollment Completion
|
English | 16.8 KB | ||
| 2025-07-21 10:00 |
Regulatory News Service
UK Axes Financial support for AMR Fleming Fund
|
English | 16.2 KB | ||
| 2025-07-21 08:00 |
Regulatory News Service
Steriwave ICU Study Completes Recruitment
|
English | 19.5 KB | ||
| 2025-07-14 08:00 |
Earnings Release
Growing Use of Steriwave Across Surgery Types
|
English | 20.2 KB |
Automate Your Workflow. Get a real-time feed of all Ondine Biomedical Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Ondine Biomedical Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
